Doxorubicin-related effects on cardiorespiratory function and body composition

Doxorubicin-related effects on cardiorespiratory function and body composition

Bibliographic Details
Main Author:	Ashley J. Smuder
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	American Heart Journal Plus
Subjects:	Cardio-oncology Exercise Chemotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S266660222400003X

Similar Items

Influence of trimetazidine on myocardium energy balance during chemotherapy with doxorubicin and cyclophosphamide
by: A. A. Avagimyan
Published: (2022-06-01)

Breast cancer chemotherapy vascular toxicity: a review of mediating mechanisms and exercise as a potential therapeutic
by: Marie Mclaughlin, et al.
Published: (2021-11-01)

Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity
by: Dong-Woo Kang, et al.
Published: (2022-01-01)

Developing a comprehensive Cardio-Oncology Program at a Cancer Institute: the Moffitt Cancer Center experience
by: Michael G. Fradley, et al.
Published: (2017-07-01)

Doxorubicin-induced cardiotoxicity is mediated by neutrophils through release of neutrophil elastase
by: Anchit Bhagat, et al.
Published: (2022-08-01)

Cardio-Oncology – A new subspecialty with collaboration at its heart
by: Arjun K. Ghosh, et al.
Published: (2017-07-01)

Cancer Therapy-Related Pulmonary Hypertension: A Review of Mechanisms and Implications for Clinical Practice
by: Muhammet Gürdoğan, et al.
Published: (2023-05-01)

Practical Approaches to Build and Sustain a Cardio-Oncology Clinic
by: Angeliki Chasouraki, et al.
Published: (2022-05-01)

Cardio-oncology: what you need to know now for clinical practice and echocardiography
by: Carolyn M Larsen, et al.
Published: (2017-04-01)

Cancer therapy-induced cardiotoxicity: Review and algorithmic approach toward evaluation
by: K Purkayastha, et al.
Published: (2017-01-01)

Atrial fibrillation in a patient with lung cancer: a case report
by: E. Yu. Shupenina, et al.
Published: (2022-12-01)

Evolving field of cardio-oncology
by: Guo Li, et al.
Published: (2023-04-01)

Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort studyResearch in context
by: Benjamin Daniels, et al.
Published: (2023-10-01)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
by: Manrose Singh, et al.
Published: (2022-01-01)

Comparison of Patients’ Phenotypes, Guideline-Directed Recommendations Compliance and Rates of Cardiotoxicity between Caribbean and United States Cardio-oncology Programs
by: Pamela Piña, et al.
Published: (2022-09-01)

Investigation of Cardio Exercise's Effects on Body Perception and Life Satisfaction in Relation with Some Parameters
by: Okan Volkan Karatan, et al.
Published: (2018-08-01)

Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case
by: A. A. Avagimyan, et al.
Published: (2021-11-01)

New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies
by: Oreste Lanza, et al.
Published: (2022-05-01)

Cardio-Oncology: Success Breeds New Challenges, Opportunities
by: Charles A. Bomzer, et al.
Published: (2014-08-01)

Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity
by: Eglė Čiburienė, et al.
Published: (2022-04-01)

Atrial Strain Assessment for the Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Women (The STRANO STUDY: Atrial Strain in Cardio-Oncology)
by: Daniela Di Lisi, et al.
Published: (2023-11-01)

The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
by: Vincenzo Quagliariello, et al.
Published: (2021-07-01)

Long-Term Risk of Death From Heart Disease Among Breast Cancer Patients
by: Aya Agha, et al.
Published: (2022-04-01)

Diagnosis, Prevention, Treatment and Surveillance of Anthracycline-Induced Cardiovascular Toxicity in Pediatric Cancer Survivors
by: Valerie Curren, et al.
Published: (2021-01-01)

Clinical Indicators of Cardiovascular Risk in Adult Patients Undergoing Chemotherapy: A Protocol for Scoping Review
by: Karolini Zuqui Nunes, et al.
Published: (2023-02-01)

Exploring the Cardiotoxicity Spectrum of Anti-Cancer Treatments: Definition, Classification, and Diagnostic Pathways
by: Ciro Mauro, et al.
Published: (2023-02-01)

Increased Risk of Cardiovascular Death in Breast Cancer Patients Without Chemotherapy or (and) Radiotherapy: A Large Population-Based Study
by: Tianwang Guan, et al.
Published: (2021-01-01)

Healthcare disparities in cardio oncology: patients receive same level of surveillance regardless of race at a safety net hospital
by: Crystal B. Chen, et al.
Published: (2021-01-01)

The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview
by: Stephen Foulkes, et al.
Published: (2020-03-01)

Trigger related outcomes of takotsubo syndrome in a cancer population
by: Ayesha Safdar, et al.
Published: (2022-10-01)

The Metabolic Fingerprint of Doxorubicin-Induced Cardiotoxicity in Male CD-1 Mice Fades Away with Time While Autophagy Increases
by: Sofia Reis Brandão, et al.
Published: (2023-11-01)

Emerging cancer in individuals with cardiovascular disease: Exploring the intersection of reverse cardio-oncology and nephropharmacology
by: Samaneh Zandifar, et al.
Published: (2024-01-01)

The Risk of Heart Disease-Related Death Among Anaplastic Astrocytoma Patients After Chemotherapy: A SEER Population-Based Analysis
by: Qi Lin, et al.
Published: (2022-06-01)

Corrigendum: The risk of heart disease-related death among anaplastic astrocytoma patients after chemotherapy: A SEER population-based analysis
by: Qi Lin, et al.
Published: (2022-08-01)

Natural Progression of Left Ventricular Function following Anthracyclines without Cardioprotective Therapy: A Systematic Review and Meta-Analysis
by: Ainsley Ryan Yan Bin Lee, et al.
Published: (2023-01-01)

Exercise Training in Elderly Cancer Patients: A Systematic Review
by: Francesco Giallauria, et al.
Published: (2023-03-01)

Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy
by: Mária Lódi, et al.
Published: (2019-07-01)

Zymosan A Improved Doxorubicin‐Induced Ventricular Remodeling by Evoking Heightened Cardiac Inflammatory Responses and Healing in Mice
by: Guiwen Xu, et al.
Published: (2023-09-01)

Oncocardiology: close collaboration between oncologists, cardiologists, and nephrologists
by: Sina Salati, et al.
Published: (2024-01-01)

Management of Cardiac Toxicity Induced by Chemotherapy
by: Dario Trapani, et al.
Published: (2020-09-01)